Introduction
Renal glutamine uptake and subsequent urinary ammonia excretion could be an important alternative pathway of ammonia disposal from the body during liver failure (diminished urea synthesis), but this pathway has received little attention. Therefore, we investigated renal glutamine and ammonia metabolism in mildly hyperammonemic, portacaval shunted rats and severely hyperammonemic rats with acute liver ischemia compared to their respective controls, to investigate whether renal ammonia disposal from the body is enhanced during hyperammonemia and to explore the limits of the pathway. Renal fluxes, urinary excretion, and renal tissue concentrations of amino acids and ammonia were measured 24 h after portacaval shunting, and 2, 4, and 6 h after liver ischemia induction and in the appropriate controls.
Arterial ammonia increased to 247±22MgM after portacaval shunting compared to controls (51±8 MAM) (P < 0.001) and increased to 934±54 MLM during liver ischemia (P < 0.001). Arterial glutamine increased to 697±93 gM after portacaval shunting compared to controls (513±40 MAM) (P < 0.01) and further increased to 3781±248 gM during liver ischemia (P < 0.001). In contrast to controls, in portacaval shunted rats the kidney net disposed ammonia from the body by diminishing renal venous ammonia release (from 267±33 to -49±59 nmol/ 100 g body wt per min) and enhancing urinary ammonia excretion from 113±24 to 305±52 nmol/100 g body wt per min (both P < 0.01). Renal glutamine uptake diminished in portacaval shunted rats compared to controls (-107±33 vs.
-322±41 nmol/100 g body wt per min) (P < 0.01). However, during liver ischemia, net renal ammonia disposal from the body did not further increase (294±88 vs. 144±101 nmol/100 g body wt per min during portacaval shunting versus liver ischemia). Renal glutamine uptake was comparable in both hyperammonemic models.
These results indicate that the rat kidney plays an important role in ammonia disposal during mild hyperammonemia. However, during severe liver insufficiency induced-hyperammonemia, ammonia disposal capacity appears to be exceeded. Receivedfor publication 31 December 1992 and in revisedform 7 July 1993.
Liver disease, whether acute or chronic, is usually accompanied by diminished hepatic urea synthesis capacity, depriving the body ofits main route ofammonia detoxification (1) . This, combined with the usually existing intra-and extrahepatic portasystemic shunting, leads to hyperammonemia (1), activating alternative pathways ofammonia detoxification. The most important of these alternative pathways probably is the synthesis ofthe amino acid glutamine from equimolar amounts ofglutamate and ammonia (2) . It is not generally recognized, however, that glutamine synthesis and subsequent expansion of tissue and plasma free glutamine pools is only a temporary and limited way of ammonia detoxification. To get the ammonia out of the body in a situation of diminished or absent urea synthesis, glutamine has to be transported to and metabolized in the kidney, after which the ammonia can be excreted into the urine.
Arterial glutamine concentrations are generally elevated during liver insufficiency-induced hyperammonemia, a phenomenon thought to be caused by enhanced skeletal muscle glutamine synthesis and release (1) . Because glutamine is the primary substrate for renal ammoniagenesis (3), the high glutamine concentrations could theoretically enhance renal ammonia disposal, and in the past some data have provided support for this theory (4) (5) (6) (7) (8) . Thus, although in cirrhotic patients the kidney continued to release ammonia into the circulation (5, 9), this release decreased at elevated ammonia concentrations (5) . Similarly, artificial hyperammonemia in healthy volunteers turned the kidney into an organ of net ammonia uptake from the circulation (6) , also suggesting enhanced renal ammonia excretion. However, the role ofthe amino acid glutamine in these metabolic processes is unclear and virtually no literature exists concerning the relation between renal ammonia and glutamine metabolism during liver insufficiency and the related hyperammonemia.
Hyperammonemia is generally thought to be an important factor in the pathophysiology of hepatic encephalopathy (1). In the treatment of liver disease, therefore, therapy is focused on keeping arterial ammonia levels low and within narrow limits. Although standard therapy aims at reducing intestinal ammonia liberation, it should be realized that especially the kidney also is an important ammonia producing organ (10) .
Therefore, the kidney could be a second target organ in developing ammonia-lowering modalities in the treatment of liver failure.
Despite the pivotal role of the kidney in nitrogen disposal and ammonia-and glutamine-related acid-base regulation (3, 9) , little is known about renal nitrogen metabolism during liver insufficiency and the related hyperammonemia. Therefore, the present experiments were designed to investigate the role ofthe kidney in ammonia and glutamine metabolism during liver disease. Specifically, we were interested in renal ammo-nia disposal from the body during liver insufficiency-induced mild and severe hyperammonemia. To this purpose we compared renal ammonia and glutamine metabolism in mildly hyperammonemic portacaval shunted rats with controls, and in addition, rats with severe hyperammonemia, induced by acute liver ischemia, were compared with their appropriate controls.
The results show that in the rat, renal ammonia and glutamine metabolism plays an important role in ammonia disposal during mild portacaval shunting-induced hyperammonemia. However, during severe liver ischemia-induced hyperammonemia ammonia disposal is not additionally enhanced, providing evidence that in this situation maximal renal ammonia disposal capacity is exceeded.
Methods
Animals. Male Wistar rats (300±25 g, n = 63) housed under standard conditions ( 12 h light/dark cycle, standard lab chow and water ad lib) were used throughout. Rats were maintained in accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals, as applied in our institute.
Groups. The following experimental groups were studied: portacaval shunting (PCS)'; control, laparotomy and manipulations as in PCS rats, but without shunting (CON); and acute liver ischemia induction (ALI).
Experimental design (11) . Surgery was carried out under ether anesthesia at constant temperature (37±1 'C). On day 0, rats were randomized for either construction of a portacaval shunt (by the button method) (PCS-group; n = 55) or sham surgery (CON-group; n = 8).
On day 1, all rats of the CON group and some randomly selected PCS rats (PCS0-group; n = 8) were subjected at t = 0 h to the sampling procedures described below. These two groups were compared to address the role of the kidney in mild liver insufficiency-induced hyperammonemia. Also on day 1, half of the remaining PCS rats were subjected at t = 0 h to acute liver ischemia induction by hepatic artery ligation, and sampling 2, 4, or 6 h later (ALI2, 4 or 6 group; n = 8 per time point). The remainder underwent a sham procedure at t = 0 in which the hepatic artery was identified but not ligated, and sampling was performed 2, 4, or 6 h later (PCS2, 4 or 6 group; n = 7 or 8 per time point). The latter two groups were compared to address the role of the kidney during severe liver insufficiency-induced hyperammonemia.
Miscellaneous. Immediately following hepatic artery ligation and every hour thereafter 1 ml ofa 5% glucose solution was given intraperitoneally to prevent hypoglycemia ( 11 ) . Rats subjected to hepatic artery identification (PCS2, 4 and 6 groups) received normal saline intraperitoneally. Hourly temperature was measured and level ofconsciousness was judged using a 6 stage coma scale as described previously ( 12) (scale 0 to 5; 0 = normal, 5 = coma). During acute liver ischemia, hepatic encephalopathy progressed to loss of spontaneous righting reflex at t = 6 h as described previously (1 1, 12 ), but no coma was observed. In all other rats no major behavioral changes were observed.
Sampling. Sampling procedures were performed as described in detail recently ( 13 (11, 13, 14) . At steady state, a 15-min urine collection was done on ice, quantified ( -7 qI / min), diluted with icecold distilled water, and immediately immersed in liquid nitrogen.
Next, 1 ml ofblood was withdrawn simultaneously from the renal vein and carotid artery. Finally, the kidney was frozen in liquid nitrogen. Rats were killed by an overdose ofthe anesthetic. The resulting arterial para-aminohippuric acid concentrations (< 70 MM) are not likely to influence renal ammoniagenesis ( 15) . Also, our urine data in control rats are comparable to studies in which no para-aminohippuric acid was used ( 15, 16) , providing evidence for the reliability of this urine sampling method. Biochemical analysis. Samples were kept on ice during processing. Hematocrit was obtained with a microfuge. Centrifugations were performed at 4VC during 5 min at 8,800 g. Plasma was put in liquid nitrogen within 20 min. Plasma and tissue samples were stored at -70'C until further processing. Tissue ammonia, amino acids, and water content were determined in 5% sulfosalicylic acid (wt/vol) extracts (1 1, 17) . In plasma and urine, ammonia and urea were determined enzymatically, and amino acids by HPLC technique as described previously ( 1 1, 13). Para-aminohippuric acid was determined by standard techniques after deacetylation (45 min, 1000C; reference 11). The coefficient of variance for all determinations was < 4% (e.g., 4% for ammonia, 2% for glutamine; reference 11).
pH Measurements. In some CON, PCS6, and ALI6 rats (n = 3 per group) arterial blood was sampled anaerobically for blood pH at the beginning and end of the 15-min urine collection. Finally, urine pH was measured in bladder urine. Samples were kept on ice and determined on an ABL520 blood gas analyzer (Radiometer, Copenhagen, Denmark).
Calculations. Urea values were corrected for ammonia. Plasma para-aminohippuric acid concentrations were calculated using whole blood para-aminohippuric acid concentration and hematocrit. Renal plasma flow (ml/min) was calculated from the amount ofpara-aminohippuric acid infused and renal venous-arterial para-aminohippuric acid extraction using standard equations ( 11, 13, 18 (Table I) . Arterial concentrations were comparable to those described previously in the same models ( 1) . Arterial ammonia concentrations (Fig. 1) were elevated pHi-Ie/post: Arterial blood sampled at the beginning/end of the 1 5-min urine collection.
in PCSO compared with CON rats and were grossly elevated in ALI rats compared to PCS2, 4, and 6 controls. Arterial concentrations ofglutamine (Fig. 3) were elevated in PCSO compared with CON rats. In ALI rats compared with the PCS2, 4, and 6
groups an increase of glutamine levels to 3,800 ,uM at t = 6 h was observed. Although arterial pH at the start of urine collections was slightly higher in ALI6 than in PCS6 rats, it did not differ from CON rats and was in the physiological range.
Renal ammonia handling (Tables II-V, Figs. I and 2).
Renal plasma flow did not significantly differ between groups (Table II) . In CON rats, net ammonia release into the circulation was observed (Figure 1, right Table I .
rats compared with their PCS2, 4, and 6 controls, urinary ammonia excretion was slightly higher. Kidney ammonia (Fig. 1 , right lower panel) concentrations were elevated in PCSO compared with CON rats, and increased in ALI compared with their PCS2, 4, and 6 controls. The overall effect of these changes in renal ammonia fluxes and urinary excretion is easier to interpret by looking at the kidney as an organ of net ammonia disposal from or addition to the body ammonia pools (Fig. 2, Table V ). In CON rats ammonia release into the renal vein exceeds urinary ammonia excretion and therefore in this group the kidney is an organ of net ammonia addition to the body pools (Fig. 2 , left upper panel; negative disposal). In sharp contrast, in PCSO rats the kidney reversed to net ammonia disposal from the body (P < 0.01, PCSO vs. CON). The kidney also proved to be a net ammonia disposal organ in rats subjected to acute liver ischemia (ALI) induction, but in this group ammonia disposal was not significantly different from that observed in their portacaval shunted controls (PCS2, 4, and 6 groups). The mechanism ofthe switch to net ammonia disposal in the PCSO compared to CON group appeared to be a decrease in total renal ammoniagenesis (Fig. 2 , right upperpanel) (P < 0.01 ) and an increase in the absolute urinary ammonia excretion as well as the fraction of total renal ammoniagenesis excreted in the urine (Fig. 2 , lower panels) (P < 0.01). In the liver ischemia rats fractional ammonia excretion and total renal ammoniagenesis were similar to their PCS2, 4, and 6 controls, except for an elevated total renal ammoniagenesis at t = 6 h in the ALI group.
Renal glutamine handling (Tables 2-4, Fig. 3 ). In all groups glutamine was taken up by the kidneys (Fig. 3, right  upper panel) . In PCSO rats glutamine uptake was decreased compared with CON rats, compatible with the decreased total renal ammoniagenesis. No differences in glutamine uptake were observed between ALI and PCS2, 4, and 6 rats, also compatible with the observed total renal ammoniagenesis.
Urinary glutamine excretion was comparable in PCSO and CON rats (Fig. 3, left lower panel) . In ALI rats a progressive increase in urinary glutamine excretion was observed, reaching levels fivefold elevated at t = 6 h compared with PCS rats subjected to hepatic artery identification. However, urinary glutamine excretion still was less than 5% ofrenal glutamine uptake in the ALI group. Kidney glutamine levels (Fig. 3 , right lower panel) were elevated in PCSO compared with CON rats, and increased in ALI compared with PCS2, 4, and 6 rats.
Discussion
In the present experiments the role of the kidney in ammonia metabolism during liver insufficiency and the related hyperammonemia was studied. Specifically, we were interested in whether the kidney plays a role in ammonia disposal during hyperammonemia, and whether this disposal capacity has an upper limit during severe hyperammonemia. To address the first question, we compared renal ammonia handling in portacaval shunted rats with that in sham operated controls. Portacaval shunting is a reproducible rat model for studying various aspects of liver insufficiency, among which are the effects of mild hyperammonemia (21 ) . To address the second part ofthe question, we compared renal ammonia metabolism in rats with acute liver ischemia with that in portacaval shunted rats subjected to hepatic artery identification (ALI versus PCS2, 4, and 6). Like portacaval shunting, the liver ischemia rat model is reproducible and has been used extensively to study various aspects of severe acute liver failure and hyperammonemia ( 1 1, 22, 23) . Theoretically, adaptation of the kidney to hyperammonemia could be assumed to require increased renal uptake Table I .
Renal Metabolism during Hyperammonemia 2837 10932±879'   9284±563m  9823±408cfim  GLU  3832±244  3437±272  3640±303  3627±228  3690±175  4058±445  4943±485k   4528±318behk   GLN  -1060±149  1621±174k  1312±111  1326±82  1524±161  3569±278m  4745±236m   8194±723cfimn Data are means±SEM in ,umol/kg wet wt, except tissue water content (%H20). For significance symbols, see Table I. of blood-derived glutamine, decreased ammonia release into the renal vein, and increased urinary ammonia excretion (6), either apart or in combination. Ammonia. In the physiological situation, renal ammoniagenesis results from the de-amidation of glutamine mainly by intra-mitochondrial phosphate-dependent glutaminase (3, 4, 20) . Only minor quantities (± 10% ) are produced by the brush border membrane-bound y-glutamyl transferase in the distal parts of the proximal tubule (4). In the physiological situation -70% oftotal renal ammoniagenesis is released into the renal vein, the remainder being excreted in the urine (3). Renal vein ammonia release and urinary ammonia excretion in CON rats in our study are comparable with literature (3, 16) .
In CON rats, ammonia release into the renal vein was observed. In PCSO rats, however, ammonia release into the renal vein stopped, and simultaneously urinary ammonia excretion was increased. These combined changes reversed the kidney from an organ of net ammonia addition to the body pools in CON rats, to an organ of net ammonia disposal in PCSO rats. Another important observation was that total renal ammoniagenesis was diminished in PCS0 compared with CON rats. Thus, the kidney appears to play a very important role in the adaptation to mild hyperammonemia by reducing total ammoniagenesis and increasing the fraction oftotal ammoniagenesis excreted in the urine, thereby rendering the kidney into an organ of net ammonia disposal.
Recently, we reported in the same models ( 11 ) that intestinal ammonia production was 314±74 nmol/ 100 g body wt per min in the PCSO group. Because renal ammonia disposal in the present study in PCSO rats was 260±78 nmol/ 100 g body wt per min, it appears that the altered renal ammonia handling during portacaval shunting is sufficient to compensate for most of the gut-derived ammonia entering the circulation during portacaval shunting. However, during liver ischemia, intestinal ammonia generation ( 11 ) by far exceeded the observed renal ammonia disposal in the present study, contributing to progressive hyperammonemia. In recent studies, we have shown that in these models brain ( 17) and muscle ( 11 ) play a role in ammonia uptake and glutamine release, although the role ofskeletal muscle appears to have been overestimated in literature. Apparently, several organs contribute to the alternative ammonia detoxification pathway consisting of glutamine synthesis, glutamine transport to the kidney, and ammonia excretion in the urine. Also, because the lung is capable of producing and releasing considerable amounts of glutamine (24), the lung could play a role in the alternative ammonia detoxification pathway, but this remains to be established.
Comparison of rats with acute liver ischemia and their portacaval shunted controls (PCS2, 4, and 6) revealed that the kidney was an organ of net ammonia disposal in both groups. However, no differences in ammonia disposal were observed, nor were there any significant differences in the fraction oftotal ammoniagenesis excreted in the urine. Thus, it appears that in the acute liver ischemia model, during severe hyperammonemia, the renal capacity to enhance ammonia disposal is exceeded. This appears to be in agreement with results obtained in studying the effects of acidosis on renal ammonia excretion (3) .
Glutamine. Conflicting results have been reported concerning glutamine fluxes across the normal rat kidney ( 14-16, 18, 25) . Most of these studies show net renal glutamine uptake, but some don't (25) . The present study provides additional evidence that the normal rat kidney is an organ of net glutamine uptake. In the PCSO group glutamine uptake was diminished compared with CON rats, which could contribute to expansion of the free plasma and tissue glutamine pools. The reduced renal glutamine uptake was reflected in a diminished total renal ammoniagenesis in the PCSO group. Glutamine uptake was similar in ALI rats and in their PCS2, 4, and 6 controls, compatible with the observation that renal ammonia disposal is not enhanced in ALI rats compared with their PCS2, 4, and 6 controls. Also, the similar glutamine uptake despite increased arterial glutamine concentrations in the ALI rats suggests that renal glutamine uptake and subsequent ammonia disposal is not solely regulated by arterial glutamine levels. The actual regulatory mechanism remains to be determined. Renal (8) and seems the best explanation for our observations. Because the kidney contains very little glutamine synthetase (26), this is not a likely explanation for the changes.
The effects of acid-base changes on kidney ammonia and glutamine metabolism have been extensively studied (for review see references 3 and 4). Metabolic acidosis, whether acute or chronic, induces enhanced renal glutamine extraction (7, 18) and increased urinary ammonia excretion (7) at the expense of urea excretion, whereas total urinary nitrogen excretion as ammonia plus urea remains constant ( 14) . In contrast, respiratory alkalosis in cirrhotic patients enhances renal venous ammonia release, thus reducing renal ammonia disposal (9) . However, in the present studies, only minimal pH changes were observed within the physiological range as observed by others in the same model (22) , making an influence of pH on the observed changes unlikely. Nonetheless, the changes in fraction of renal ammoniagenesis excreted in the urine closely resembled those observed in studies during acidosis. Thus, it is known that during acidosis the fraction of ammonia excreted in the urine rises to 70%, thereby reversing the urine/renal vein ammonia partition ratio (normally 30/70 as in reference 3). This might suggest that a common pathway is involved in acidosis-and hyperammonemia-induced enhanced urinary ammonia excretion, which does not seem to be mediated by arterial or urine pH. However, the mechanism underlying the observed reversal of renal ammonia addition to the body pools in controls, as it changes to ammonia disposal during hyperammonemia, cannot be deduced from our experiments.
Recently, it has become increasingly clear that renal ammonia excretion into the urine cannot be explained simply as pHdependent (the "diffusion-trapping" system discussed in reference 3). Instead, other factors (e.g., tubular urine flow, several ion exchangers, and the ammonia counter-current system) appear to be more important than tubular pH in the regulation of urinary ammonia excretion (3, 27, 28, 29) . It is beyond the scope of this paper to discuss these regulatory mechanisms in detail, but if it were possible to influence any of these processes involved in ammonia excretion, this could provide a fruitful area for developing new therapeutics in the treatment of hyperammonemia.
Conclusion. This study shows that during portacaval shunting in rats, the kidney plays an important role in ammonia disposal during mild hyperammonemia by diminishing renal ammoniagenesis and enhancing the fraction of renal ammoniagenesis excreted in the urine, thereby turning into an organ of net ammonia disposal. During severe acute hyperammonemia induced by liver ischemia, however, the kidney does not additionally enhance net ammonia disposal from the body, providing evidence that in this situation the capacity of the renal ammonia system to excrete ammonia is exceeded.
